Courtney Beers
Vermogen: 8 475 $ op 30-09-2026
Vermogen: 8 475 $ op 30-09-2026
Courtney Beers is currently an Independent Director at Sangamo Therapeutics, Inc. since 2022 and Chief Scientific Officer at Tizona Therapeutics, Inc. since 2019.
Formerly, Dr. Beers was Head of Cancer Immunotherapy at Cascadian Therapeutics LLC.
Dr. Beers earned a doctorate from the University of Washington.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 57.650 ( 0,01% ) | 8 475 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Directeur/Bestuurslid | 15-12-2022 |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau